Geographical distribution of the Cryptococcus gattii species complex: a systematic review.


Journal

The Lancet. Microbe
ISSN: 2666-5247
Titre abrégé: Lancet Microbe
Pays: England
ID NLM: 101769019

Informations de publication

Date de publication:
24 Aug 2024
Historique:
received: 24 01 2024
revised: 04 06 2024
accepted: 06 06 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 27 8 2024
Statut: aheadofprint

Résumé

The taxonomy of the Cryptococcus gattii species complex continues to evolve, and has been divided into five pathogenic species. The objective of this systematic review was to summarise the geographical distribution of the C gattii species complex and the species within the C gattii species complex. We searched PubMed for articles related to human, animal, ecological, or laboratory-based studies of C gattii species complex isolates with traceable geographical origin published from January, 1970, until September, 2021. Having extracted their geographical origin, we used ArcMap to construct maps according to the highest degree of resolution allowed by their reported taxonomy, to reflect the most likely area of transmission on the basis of published reports of human isolates. 604 such articles were included in the study. This review indicated that although C gattii species complex isolates have been reported globally, understanding their heterogeneous geographical distribution by species can have implications for researchers and clinicians in formulating research questions and considering diagnostic quandaries.

Identifiants

pubmed: 39191262
pii: S2666-5247(24)00161-7
doi: 10.1016/S2666-5247(24)00161-7
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100921

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests FH is the Vice President of the International Society for Human and Animal Mycology, treasurer of the Netherlands Society for Medical Mycology, chair of the Royal Netherlands Society for Microbiology, Microbial Genomic Division, and received molecular diagnostic kits from Bruker Molecular Diagnostics. NCB was the Data and Safety Monitoring Board chair for NCT04335123. All other authors declare no conflicts of interest.

Auteurs

Victoria Poplin (V)

Division of Infectious Diseases, Department of Medicine, University of Kansas, Kansas City, KS, USA. Electronic address: vpoplin@kumc.edu.

Clarissa Smith (C)

Department of Internal Medicine, University of Kansas, Kansas City, KS, USA; Section of Pulmonary/Critical Care, Department of Medicine, University of Chicago, Chicago, IL, USA.

Diego H Caceres (DH)

Immuno-Mycologics (IMMY), Norman, OK, USA; Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, Netherlands; Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.

Patricia F Herkert (PF)

Faculty of Medicine, Centro Universitário de Pato Branco, UNIDEP, Pato Branco, Brazil.

Olujimi Jegede (O)

Division of Infectious Diseases, Department of Medicine, University of Kansas, Kansas City, KS, USA.

George R Thompson (GR)

Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA, USA; Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento, CA, USA.

John W Baddley (JW)

Division of Infectious Diseases, Department of Medicine, University of Maryland, Baltimore, MD, USA.

Ilan S Schwartz (IS)

Division of Infectious Diseases, Department of Medicine, Duke University, Durham, NC, USA.

Ryan Kubat (R)

Division of Infectious Diseases, Department of Medicine, University of Kansas, Kansas City, KS, USA.

Mark A Deka (MA)

Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Mitsuru Toda (M)

Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Shawn R Lockhart (SR)

Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Tom Chiller (T)

Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Ferry Hagen (F)

Department of Medical Mycology, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands; Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, Netherlands; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.

Nathan C Bahr (NC)

Division of Infectious Diseases, Department of Medicine, University of Kansas, Kansas City, KS, USA; Division of Infectious Diseases and International Medicine, Department of Internal Medicine, University of Minnesota, Minneapolis, MN, USA.

Classifications MeSH